See more : Mercury NZ Limited (MCY.AX) Income Statement Analysis – Financial Results
Complete financial analysis of Allied Corp. (ALID) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Allied Corp., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Central Pacific Financial Corp. (CPF) Income Statement Analysis – Financial Results
- Dream Residential Real Estate Investment Trust (DRREF) Income Statement Analysis – Financial Results
- Helium One Global Ltd (HE1.L) Income Statement Analysis – Financial Results
- RFHIC Corporation (218410.KQ) Income Statement Analysis – Financial Results
- SPARQ Corp. (SPRQF) Income Statement Analysis – Financial Results
Allied Corp. (ALID)
About Allied Corp.
Allied Corp., a medical cannabis production company, engages in the research, development, and production of cannabinoid health solutions in the United States. It offers hemp-derived natural health products, including Liberty, a hemp-derived cannabidiol (CBD) tincture; Tactical Hydration, a CBD infused electrolyte replacement drink; FIZZ Tablets for adding in a water bottle; Battle Balm, a CBD roll on activity rub for aches and pains; and Quick Hit, a CBD gummy under the Tactical Relief brand. The company also provides Hydrosport CBD Drink, a CBD infused electrolyte replacement drink with sodium citrate electrolyte replacement; Hydrosport Tincture, a CBD tincture fortified with specific terpene profile; FIZZ Tablets for adding to a water bottle; Sport Rub, a CBD post-activity rub for aches and pains; and Quick Hit, a CBD gummy with vitamin B12 under the Equilibrium Bio brand. In addition, it offers Skin Structure, a facial formula topically applied to enhance skin's radiance and youthfulness; Eye Recover that helps the eye skin ward off free radicals, as well as helping to protect against sun damage; Glossy Lip Recover, which moisturizes and nourishes lips; Skin Designer that stimulates cell regeneration while minimizing age spots; Vitamin Absolute, a moisturizing facial oil; and Absolute Recover, a formulation that allows the infused bioactive compounds to be delivered directly to the desired areas of inflammation, pain, and other skin ailments under the MaXXa brand. In addition, it is developing ALID 10 and ALID 11, a pharma product, which is in Phase I clinical trial for treating post-traumatic stress disorder. The company was incorporated in 2013 and is headquartered in Kelowna, Canada.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 72.10K | 165.60K | 12.52K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 9.00K | 0.00 |
Cost of Revenue | 1.53M | 91.48K | 637.99K | 90.54K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | -1.46M | 74.12K | -625.47K | -90.54K | 0.00 | 0.00 | 0.00 | 0.00 | 9.00K | 0.00 |
Gross Profit Ratio | -2,027.53% | 44.76% | -4,996.60% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 0.00% |
Research & Development | 0.00 | 12.06K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 5.22M | 14.25M | 5.81M | 2.82M | 23.11K | 19.25K | 20.25K | 2.06K | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 5.22M | 14.25M | 5.81M | 2.82M | 23.11K | 19.25K | 20.25K | 2.06K | 0.00 | 0.00 |
Other Expenses | 8.36M | 126.26K | 557.88K | 466.87K | 0.00 | 0.00 | 0.00 | 0.00 | -16.53K | 0.00 |
Operating Expenses | 5.37M | 14.38M | 6.37M | 3.29M | 23.11K | 19.25K | 20.25K | 2.06K | -16.53K | 0.00 |
Cost & Expenses | 6.90M | 14.48M | 7.01M | 3.29M | 23.11K | 19.25K | 20.25K | 2.06K | -16.53K | 0.00 |
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 863.20K | 1.23M | 625.42K | 148.24K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 137.05K | 82.59K | 547.48K | 466.04K | 171.86K | 161.14K | 52.52K | 22.82K | 0.00 | 0.00 |
EBITDA | -6.69M | -14.23M | -7.05M | -3.04M | -23.11K | -19.25K | -20.25K | -2.06K | -7.53K | 0.00 |
EBITDA Ratio | -9,284.79% | -8,591.36% | -56,332.09% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -83.66% | 0.00% |
Operating Income | -10.26M | -14.31M | -7.60M | -3.51M | -23.11K | -19.25K | -20.25K | -2.06K | -7.53K | 0.00 |
Operating Income Ratio | -14,235.43% | -8,641.23% | -60,705.62% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -83.66% | 0.00% |
Total Other Income/Expenses | -2.98M | -1.23M | -3.89M | -3.10M | -23.11K | -19.25K | 0.00 | 0.00 | 0.00 | 0.00 |
Income Before Tax | -10.68M | -15.54M | -11.49M | -6.61M | -23.11K | -19.25K | -20.25K | -2.06K | -7.53K | 0.00 |
Income Before Tax Ratio | -14,807.58% | -9,383.59% | -91,749.85% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -83.66% | 0.00% |
Income Tax Expense | 863.20K | 1.23M | 673.94K | 154.77K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income | -10.68M | -16.77M | -12.16M | -6.76M | -23.11K | -19.25K | -20.25K | -2.06K | -7.53K | 0.00 |
Net Income Ratio | -14,807.58% | -10,128.99% | -97,133.62% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -83.66% | 0.00% |
EPS | -0.11 | -0.18 | -0.15 | -0.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EPS Diluted | -0.11 | -0.18 | -0.15 | -0.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Weighted Avg Shares Out | 96.80M | 92.10M | 80.39M | 80.75M | 86.66M | 86.66M | 13.00M | 13.00M | 0.00 | 0.00 |
Weighted Avg Shares Out (Dil) | 96.80M | 92.10M | 80.39M | 80.75M | 86.66M | 86.66M | 13.00M | 13.00M | 0.00 | 0.00 |
Allied Corp Announces Signing of Supply Contracts of 85,000, 40,000 and 24,000 Kilograms for the 2022 Calendar Year
Allied Corp Announces Approval of Research and Plant Breeding License for Psychoactive and Non-Psychoactive Cannabis in Colombia
Allied Corp Provides Results of Recent Third Party Audit Confirming Production Costs and Optimization of Production
Allied Corp. Announces Approval of Second CBD Isolate Import Permit for Australia and Submits Application for the Import of Dried Cannabis
Allied Corp Provides Update Regarding Nevada Building and Option to Purchase Nevada State License
Allied Corp. Advances Psilocybin Product Psilonex™ RX and Initiates Manufacturing Process
Allied Corp. Initiates Additional Shipment of 200kgs of CBD Distillate From Colombia to Nevada, United States
Allied Corp. Signs Additional Supply Contracts for the Export of Cannabis Flower and CBD Isolate From Colombia to Australia
Allied Corp Initiates Additional Commercial CBD Shipment From Colombia Destined for Colorado, United States
Allied Corp Completes Commercial CBD Shipments From Colombia Into Australia
Source: https://incomestatements.info
Category: Stock Reports